基于药代动力学原理的非线性分析确定肝脏CT增强对比剂剂量以改善体尺寸依赖性
研究提出一种药代动力学非线性分析方法,用于确定肝脏CT增强的对比剂剂量,以改善体尺寸依赖性。基于105例固定剂量动态CT增强数据模拟,并在体重两臂临床研究中验证;结果显示所提方法较常规方法显著改善体重、瘦体重和血容量依赖性,仅用体重(无需身高信息)即可作为改善体尺寸依赖性的合适指标。
要点
- 所提非线性药代动力学方法可显著降低体重、瘦体重、血容量与肝增强之间的相关性(p<0.05)。
- 临床两臂研究显示,仅用体重确定对比剂剂量即可改善体尺寸依赖性,平均绝对误差显著降低(p<0.001)。
- 常规固定对比剂剂量方案存在体尺寸依赖性,所提方法在模拟与临床研究中均显示改善。
诊断标准与关键数值
- 体尺寸依赖性评估:体尺寸指标与增强之间相关系数的p值,p<0.05为显著依赖。
- 模拟结果显示体重、瘦体重和血容量的MAE均显著降低(p<0.05)。
- 两臂临床研究(体重)显示MAE显著降低(p<0.001),改善趋势与模拟结果相似。
临床应用与阅片要点
- 作者认为,仅用体重(无需身高信息)确定对比剂剂量是改善体尺寸依赖性的合适指标。
- 所提药代动力学非线性分析方法可用于确定肝脏CT增强对比剂剂量以改善体尺寸依赖性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To propose a pharmacokinetic non-linear analysis method to determine contrast medium (CM) dose for computed tomography (CT) hepatic enhancement to improve body size dependency and validate the proposed CM dose determination method through a clinical study.
MATERIALS AND METHODS: Enhancement data of 105 patients who underwent hepatic dynamic CT with a fixed CM dose were analysed. From the analysis results, CM doses as a function of each of four body size indices (body weight [BW], lean body weight [LBW], blood volume [BV], and body surface area [BSA]) for achieving improved body size dependency were determined (proposed method), and the body size dependencies were simulated using the enhancement data from 105 patients. The proposed method was validated with a two-arm clinical study on BW. Body size dependency was evaluated using p-value of correlation coefficient between Body size indices and enhancements (p<0.05: significant dependency) and mean absolute error (MAE).
RESULTS: The simulation showed that significant body size dependencies not considered by the conventional method can be improved by the proposed method. MAEs of BW, LBW, and BV were also significantly reduced (p<0.05). The clinical study with BW demonstrated a similar improvement to that in the simulation result. MAE was also significantly reduced (p<0.001).
CONCLUSION: The proposed method demonstrated more improved BW, LBW, and BV dependence compared to the conventional method. Through the two-arm clinical study, the proposed method using BW only, without height information, is a suitable index for improving body size dependency.
引用
- Hibino T, Ichikawa K, Fang Y, et al. Determination of contrast medium dose for hepatic CT enhancement with improved body size dependency using a non-linear analysis based on pharmacokinetic principles. Clin Radiol. 2019. PMID: 31679815. doi:10.1016/j.crad.2019.09.140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。